Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Radiotherapy × Clear all

NCT03267888 2024-09-04

Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

25 enrolled 11 charts

Multiple Myeloma